Background: β -thalassemia is a group of inherited blood disorders that causes iron overload in the heart. Development of overt heart failure is delayed till the second decade of life. Early detection of cardiac iron overload is necessary before development of heart failure.
Introduction
THALASSEMIA is an Inherited hemoglobinrelated disorder which affects more than 300,000 children annually, particularly in malaria-endemic regions stretching from sub-Saharan Africa and the Mediterranean to Southeast Asia, Early clinical recognition of these disorders is essential [1] . Iron overload is an important clinical challenge in patients with thalassemia. It occurs primarily as a result of increased intestinal iron absorption but also can result from blood transfusion therapy [2] .
Life expectancy in patients with thalassaemia major is still limited by development of congestive heart failure due to a cardiomyopathy associated with iron over-load [3] .
Echocardiography is a useful and noninvasive diagnostic tool for diagnosis of heart disorders and helps with early detection of heart failure before the development of symptoms. Therefore, serial echocardiography is recommended in asymptomatic patients with ß-thalassemia for early diagnosis of heart dysfunction [4] .
2D strain analysis technique is a new method for assessment of myocardial function. It offers many advantages as it is less time-consuming, angle independent, can assess strain in 3 dimensions (longitudinal, circumferential, and radial), semiautomated and gives information about global as well as segmental systolic strain [5] .
Magnetic resonance imaging (MRI) by the T2* technique: Allows highly reproducible and noninvasive quantifications of myocardial iron burden. Moreover, MRI is the gold standard for quantifying biventricular function parameters [6] .
Aim: To evaluate cardiac function in children with β -thalassemia major having iron overload and to compare MRI T2* and Doppler echocardiography in demonstration of iron deposition in cardiac muscles in those patients.
Patients and Methods
This study was carried out upon 50 patients with β -Thalassemic. These thalassemic children were selected from patients admitted to Heamatology unit, pediatric department, Tanta University Hospital during the period from October 2016 to October 2017, and 20 healthy children served as a control group.
All patients were subjected to:
A-Full history taking and thorough clinical examination. B-Investigations: Complete blood picture. Iron profile (serum iron -ferritin -total iron binding capacity) C-Cardiac iron concentration measurement: By MRI and two dimensional strain of echocardiography.
Statistical presentation and analysis of the present study was conducted using the mean, standard deviation, student t-test, Chi-square by SPSS V20 with p<0.05 means significance.
Results
This study was carried out upon 70 children (50 patients and 20 control).
Table (1) show that there was statistically significant difference between the patients and the control groups as regard MPI, EF, SPI, L, C, A and R. (p-value <0.05). MPI, EF, L, C, A and R increased in control groups than patients groups while SPI decreased in patients than control groups. There was no statistically significant difference between the patients and the studied groups as regard S, (È/À) and 2DS ( p-value >0.05. (2) show that there was negative correlation between cardiac MRI T2* with MRI R2 ( pvalue <0.05). There was also negative correlation between cardiac MRI T2* with age (p-value <0.05). There was negative correlation between cardiac MRI T2* with serum ferritin level (p-value <0.05). There was negative correlation between cardiac MRI T2* with serum iron level ( p-value <0.05). There was positive correlation between cardiac MRI T2* with TIBC (p-value<0.05), also there was positive correlation between cardiac MRI T2* with Echo MPI (p-value <0.05). There was positive correlation between cardiac MRI R2 with iron level (p-value <0.05). There was negative correlation between cardiac MRI R2 with TIBC ( p-value <0.05). There was no correlation between MRI T2* with weight, height, BMI, HB, platelets, TLC, Echo S, Echo È/À, Echo 2DS, Echo EF, Echo SPI, Echo L, Echo C, Echo A and Echo R. ( p-value >0.05). There was no correlation between MRI R2 with weight, height, BMI, HB, platelets,TLC, ferritin, Echo S, Echo È/À, Echo MPI, Echo 2DS, Echo EF, Echo SPI, Echo L, Echo C, Echo A and Echo R (p-value >0.05). 
Discussion
This study showed that the mean of ejection fraction (EF) of children with thalassemia was significantly lower than the control group. This means that these children suffered from left ventricular systolic dysfunction, which was in accordance to the study of (Abdelmoktader et al., 2013) who reported at their study of the value of pulsed tissue Doppler imaging in early detection of left ventricular dysfunction in asymptomatic children with beta thalassemia that EF was significantly lower in patients with thalassemia than control.
This study also showed that there was significant increase in stroke power index or sphericity index (SPI) in patients than the control group. SPI is a sensitive parameter for detecting left ventricular remodeling which develop early before the development of cardiomyopathy, that's why it is affected earlier than other parameters.
This study showed that mean MPI of patients with thalassemia was higher than the control group with high significant difference between both groups which means that left ventricular systolic and diastolic functions of the studied group of patients with thalassemia was affected without showing any symptom of heart failure. This was in accordance with the study of Uçar et al., [8] who reported that mean MPI of patients with thalassemia was significantly higher than that of control group and concluded that MPI taken by tissue Doppler imaging (TDI) can be an early parameter for early detection of left ventricular dysfunction.
In this study, as regard other TDI parameters; S and E'/A' ratio, there were no statistically significant difference between both groups.
Also, there was a significantly lower longitudinal strain (LS) in patients with thalassemia compared to controls which means that there were left ventricular dysfunction in those thalassemia patients without any cardiac symptoms.
Monte et al., [9] agreed with us as their patients with thalassemia showed significantly low LS if compared to controls.
Regarding this study there were highly significant difference between both groups as regard circumferential strain (CS) which means that there was left ventricular dysfunction in patients with thalassemia without any cardiac symptoms.
Monte et al., [9] agreed with us as their patients with thalassemia showed significantly low CS if compared to controls.
In this study there was a highly significant low radial strain (RS) in patients with thalassemia than control which means that there were left ventricular dysfunction in patients with thalassemia without any cardiac symptoms.
Monte et al., [9] agreed with us as their studied patients with thalassemia showed significantly low RS if compared to controls.
There was a highly significant low area strain (AS) in patients with thalassemia than the control group in this study, which means that there was left ventricular dysfunction concerning the subendocardial surface of patients with thalassemia without any cardiac symptoms. Also, this study showed that there was a highly significant correlation between AS and EF. Li et al., [10] agreed with our results concerning area strain and also showed higher correlation with LVEF which coincide with our results.
Felix Liauw et al., [11] categorized cardiac T2* as severe (T2*<10ms), moderate (10<T2* <14ms), mild (14<T2*<20ms), and acceptable (T2*>20ms).
In this study, we found that T2* ranged from 2.8-109ms. Normal cases were 32 with T2* ranging from 25-109ms. Mild cases were 4 with T2* ranging from 12. 6-18.8ms . Moderate cases were 6 with T2* ranging from 9.4-11.7ms. Severe cases were 8 with T2* ranging from 2.8-5.5ms.
Also this study showed that there was a negative correlation between MRI T2* values with age. This is in agreement with Oliveri NF, Brittenham GM. 2007 who demonstrated that when age is increasing the level of iron is increased in patients with thalassemia.
It is currently accepted that MR relaxometry is the method of choice for non-invasive and accurate measurement of iron load. (MAVROGENI et al., 2011) . The data can be obtained in a single breath hold. Myocardial iron overload causes decrease of values of T2* because iron interferes with local magnetic field homogeneity [14] .
Decreasing cardiac T2* values correspond with increasing levels of cardiac iron and increasing risk of cardiac dysfunction [15] .
Iron, typically in the form of ferritin and hemosiderin, shortens the relaxation times T2*, T2, and Tl, and increases the relaxation rates R2*, R2, and R1. (Hernando et al., 2014).
Also this study showed that MRI T2* is inversely proportional to ferritin level, while MRI R2 is directly proportional to ferritin level.
This study showed that there was a positive correlation between MRI T2* results and Tei index in patients with thalassemia. This result was in agreement with AESSOPOS et al., [17] . As Tei index is independent of arterial pressure, heart rate, ventricular geometry, atrioventricular valvular regurgitation, and pre-and after load so it is a sensitive modality for detection of cardiac affection.
The present study showed that there was no correlation between other echocardiographic parameters and MRI T2* value. These findings agreed with Karan et al., [18] who found that the correlation was not strong, and the echo parameters showed low sensitivity.
This study showed that, there was no correlation between serum ferritin level with any of echocardiographic parameters. This agrees with Mavrogeni et al., [19] who found a poor correlation between iron load and ventricular function, but this may reflect the inadequacy of serum ferritin levels or the number of blood transfusions as predictors of myocardial iron status.
Conclusion:
There is a good correlation between cardiac MRI T2* and Tei index in detection of cardiac affection in patients with thalassemia.
